¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"Acquired absence of breast"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • acquired tolerance
    ȹµæ³»¼º
  • hospital acquired infection
    º´¿ø°¨¿°, ¿ø³»°¨¿°
  • accessory breast
    µ¡À¯¹æ
  • breast
    À¯¹æ, Á¥, °¡½¿
  • breast augmentation
    À¯¹æÅ°¿ò(¼ú), À¯¹æÈ®´ë(¼ú)
  • breast cancer
    À¯¹æ¾Ï
  • breast examination
    À¯¹æ°ËÁø
  • breast flap
    À¯¹æÇÇÆÇ(¼ú), Á¥ÇÇÆÇ(¼ú)
  • breast implant
    À¯¹æ»ðÀÔ¹°
  • breast milk
    ¸ðÀ¯, ¾ö¸¶Á¥
  • breast milk jaundice
    ¸ðÀ¯È²´Þ
  • breast pump
    Á¥Â¥´Â±â±¸, Á¥Â¥°³
  • breast reconstruction
    À¯¹æÀç°Ç(¼ú), Á¥Àç°Ç(¼ú)
  • breast reduction
    À¯¹æÁÙÀÓ(¼ú), À¯¹æÃà¼Ò(¼ú)
  • breast-feeding
    ¸ðÀ¯¼öÀ¯, Á¥¸ÔÀÓ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • acquired perforating dermatosis
    ÈÄõõ°øÇǺκ´
  • acquired progressive lymphangioma
    ÈÄõÁøÇาÇÁ°üÁ¾
  • hospital acquired infection
    ¿ø³»°¨¿°, º´¿ø°¨¿°
  • accessory breast
    µ¡Á¥
  • breast augmentation
    À¯¹æÅ°¿ò¼ú, À¯¹æÈ®´ë¼ú
  • breast
    À¯¹æ, Á¥, °¡½¿
  • breast-feeding
    Á¥¸ÔÀÓ, ¸ðÀ¯¼öÀ¯
  • breast cancer
    À¯¹æ¾Ï
  • breast envy
    À¯¹æ¼±¸Á
  • breast feeding
    ¸ðÀ¯¿µ¾ç
  • breast flap
    À¯¹æÇÇÆÇ¼ú, Á¥ÇÇÆÇ¼ú
  • breast implant
    À¯¹æ»ðÀÔ¹°
  • breast milk
    ¸ðÀ¯, ¾ö¸¶Á¥, ¾î¹ÌÁ¥
  • breast pump
    Á¥Â¥´Â±â±¸, Á¥Â¥°³
  • breast reconstruction
    À¯¹æÀç°Ç(¼ú), Á¥Àç°Ç(¼ú)
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • absence of septum primum
    ù°»çÀ̸·°á¿©
  • absence of septum secundum
    µÑ°»çÀ̸·°á¿©
  • absence of thyroid gland
    °©»ó»ù°á¿©Áõ
  • absence of tibia
    Á¤°­»À°á¿©Áõ
  • absence of ulna
    ÀÚ»À°á¿©Áõ
  • absence seizure
    ¼Ò¹ßÀÛ
  • hepatic triglyceride lipase absence
    °£Áß¼ºÁö¹æ ¸®ÆÄÁ¦°á¿©(Áõ)
  • acquired
    ÈÄõ¼ºÀÇ
  • acquired B
    ȹµæ B Çü
  • acquired angioedema
    ÈÄõ¼º(ý­ô¸àõ) ¸Æ°üºÎÁ¾(ØæÎ·Ý©ðþ)
  • acquired blindness
    ÈÄõ¸Í.
  • acquired character
    ÈÄõÇüÁú(¡­û¡òõ).
  • acquired color vision defect
    ÈÄõ»ö°¢ÀÌ»ó
  • acquired cystic disease of the kidney
    ÈÄõ¼º ½Å³¶Æ÷Áúȯ
  • acquired deafness
    ÈÄõ(¼º) ³­Ã» ³ó
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • congenital localized absence of skin
    ¼±Ãµ¼º(à»ô¸àõ) ±¹¼Ò ÇǺΠ°á¼Õ
  • hepatic triglyceride lipase absence
    °£Áß¼ºÁö¹æ ¸®ÆÄÁ¦°á¿©(Áõ)
  • longitudinal absence
    ¼¼·Î°á¿©
  • sickness absence
    Áúº´°á±Ù(ÊÙË­Ë»), Áúº´ÈÞ¾÷(ÊÙÌ·Ëâ).
  • terminal absence
    ¸»´Ü°á¿©
  • transverse absence
    °¡·Î°á¿©
  • acquired
    ÈÄõ¼ºÀÇ
  • acquired B
    ȹµæ B Çü
  • acquired angioedema
    ÈÄõ¼º(ý­ô¸àõ) ¸Æ°üºÎÁ¾(ØæÎ·Ý©ðþ)
  • acquired blindness
    ÈÄõ¸Í.
  • acquired character
    ÈÄõÇüÁú(¡­û¡òõ).
  • acquired color vision defect
    ÈÄõ»ö°¢ÀÌ»ó
  • acquired cystic disease of the kidney
    ÈÄõ¼º ½Å³¶Æ÷Áúȯ
  • acquired deafness
    ÈÄõ(¼º) ³­Ã» ³ó
  • acquired digital fibrokeratoma
    ÈÄõ¼º ¼Õ¹ß°¡¶ô ¼¶À¯ °¢È­Á¾
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 2
CLAS congenital localized absence of skin
LOA leave of absence; Leber optic atrophy; left occipitoanterior [fetal position]
PIVKA protein induced by vitamin K absence or antagonism
SASPP syndrome of absence of septum pellucidum with preencephaly
TTA tetanus toxoid antibody; timed therapeutic absence; total toe arthroplasty; transtracheal aspiration...
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 2
or absence Presence
PIVKA-II Protein induced by vitamin K absence or antagonist II
ABI Acquired Brain Injury
AISA Acquired Idiopathic Sideroblastic Anemia
AIDS Acquired Immune Deficiency Disease Syndrome
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • feeding breast
    ¸ðÀ¯ ¿µ¾ç
  • infiltrating duct breast carcinoma
    ħÀ±¼º °ü»ó À¯¹æ ¾Ï
  • inverted nipples breast carcinoma
    ÇÔ¸ô À¯µÎ À¯¹æ ¾Ï
  • lobular breast carcinoma in situ
    ¼Ò¿±¼º, ºñħÀ±¼º À¯¹æ ¾Ï
  • mucinous breast carcinoma
    Á¡¾×¼º À¯¹æ ¾Ï
  • scirrhous breast carcinoma
    °æÁú¼º À¯¹æ ¾Ï
  • shoemaker's breast
    Á¦È­°ø Èä
  • acquired
    ȹµæµÈ, ÈÄõ¼º, ÈÄõ¼ºÀÇ, ȹµæ¼ºÀÇ
    1. ¾î¶² °ÍÀ¸·ÎºÎÅÍ ¾òÀº, »õ·Ó°Å³ª ºÎ°¡ÀûÀΠƯ¼º. 2. ½Ã°£À» °¡Áö°í ´Þ¼ºÇÏ´Â. 3. ž ¶§ºÎÅÍ °¡Áö°í ÀÖ´Â °ÍÀÌ ¾Æ´Ï°í ž ÈÄ »ýüÀÇ ¿ÜºÎ¿¡¼­ ±âÀÎÇÏ´Â ¿µÇâ¿¡ ÀÇÇÏ¿© ÀϾ´Â.
  • acquired anomaly
    ÈÄõ¼º ±âÇü
  • acquired centric jaw relation
    ÈÄõ¼º Áß½ÉÀ§ ¾Ç°£ °ü°è, ½À°ü¼º Áß½ÉÀ§ ¾Ç°£ °ü°è
  • acquired centric relation
    ÈÄõ¼º Áß½ÉÀ§, ½À°ü¼º Áß½ÉÀ§
  • acquired clotting defect
    ÈÄõ¼º ÀÀ°í °á¼Õ
  • acquired cystic disease
    ÈÄõ¼º ³¶¼º Áúȯ
  • acquired deafness
    ÈÄõ ³­Ã» ³ó
  • acquired digital fibrokeratoma
    ÈÄõ¼º ¼Õ¹ß°¡¶ô ¼¶À¯ °¢È­Á¾
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
acquired drives Those drives not directly related to biological needs; a secondary drive can be learned as an offshoot of a primary drive, in which case it is often referred to as a motive.
Synonym: acquired drives.
(05 Mar 2000)
acquired eccentric relation An eccentric relation that is assumed by habit in order to bring the teeth into occlusion.
(05 Mar 2000)
acquired epileptic aphasia <syndrome> Acquired epileptic aphasia. The typical history is that of a child whose development is normal for several years and then, either suddenly or in a fluctuating manner, loses comprehension of speech and the ability to use speech to communicate. The seizures are of no specific type, and are mostly mild and infrequent partial or atypical absences.
(12 Dec 1998)
acquired haemolytic anaemia Nonhereditary acute or chronic anaemia associated with or caused by extracorpuscular factors, e.g., certain infectious agents, chemicals (including autoantibodies or therapeutic agents), burns, toxic materials from higher plant and animal forms (including snake venoms).
(05 Mar 2000)
acquired haemolytic icterus Icterus and anaemia occuring in association with a moderate degree of splenomegaly, increased fragility of red blood cells, and increased amounts of urobilin in the urine.
Synonym: icteroanaemia.
Origin: G. Ikteros
(05 Mar 2000)
acquired hyperlipidaemia <biochemistry> A condition of elevated blood triglycerides or blood cholesterol that is a result of secondary factors (for example poor diet, drug-related causes, diabetes, hypothyroidism, Cushing's syndrome).
(27 Sep 1997)
acquired hyperlipoproteinaemia Nonfamilial hyperlipoproteinaemia that develops as a consequence of some primary disease, such as thyroid deficiency.
(05 Mar 2000)
acquired hypogammaglobulinaemia Heterogeneous group of immunodeficiency syndromes characterised by hypogammaglobulinaemia of most isotypes, variable B-cell defects, and the presence of recurrent bacterial infections.
(12 Dec 1998)
acquired ichthyosis A thickening and scaling of the skin associated with some malignant diseases (e.g., Hodgkin's disease, lymphosarcoma), leprosy, and severe nutritional deficiencies.
(05 Mar 2000)
acquired immunity <immunology> A form of cellular defense which identifies certain foreign substances (antigens) as harmful to the body. For this reason, the body can acquire resistance to a particular foreign agent.
These foreign agents are then attacked by sensitised T lymphocytes (cellular immunity). White blood cells, plasma cells, B lymphocytes and other specialised immune system cells act in concert with T lymphocytes to produce antibodies (humoral immunity) that attach to the antigen directing T-cells to attack.
Antibodies also stimulate the release of special chemical mediators in the blood (for example complement, interferon) that further enhance antigen destruction.
(13 Nov 1997)
acquired immunodeficiency disease Acquired immunodeficiency disease: Disease caused by infection with the human immunodeficiency virus (HIV).
(12 Dec 1998)
Acquired Immunodeficiency Syndrome <immunology, syndrome> An epidemic disease caused by an infection by human immunodeficiency virus (HIV-1, HIV-2), a retrovirus that causes immune system failure and debilitation and is often accompanied by infections such as tuberculosis. AIDS is spread through direct contact with bodily fluids.
Acronym: AIDS
(10 May 1997)
acquired leukoderma <dermatology> This disorder is characterised by regions of otherwise normal skin of nonpigmented white patches of varied sizes, often symmetrically distributed and usually bordered by hyperpigmented areas. Hair in the affected areas is usually, but not always, white.
(27 Sep 1997)
acquired leukopathia <dermatology> This disorder is characterised by regions of otherwise normal skin of nonpigmented white patches of varied sizes, often symmetrically distributed and usually bordered by hyperpigmented areas. Hair in the affected areas is usually, but not always, white.
(27 Sep 1997)
acquired megacolon Megacolon occurring on the basis of an acquired disease; occurs in inflammatory bowel disease (toxic megacolon) and Chagas' disease (South American trypanosomiasis).
(05 Mar 2000)
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 2
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 2
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 2
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 2
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 2
ÅëÇÕ°Ë»ö ¿Ï·á